Infliximab (Remicade)

Infliximab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Infliximab (Remicade), covering 2008-11-24 to 2024-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Reduced Infliximab Infusion Time [Phase 4]